Tumor cells depend on lipid biosynthesis to fuel proliferation, and the downregulation of lipid synthetic pathways in response to the detection of low energy status by AMPK would generally be considered unfavorable to the tumor strategy. The gene discussed is PRKAA2; the disease is neoplasm.